Canada’s pharmaceutical strategy needs the entire supply chain

If Canada is serious about pharmaceutical sovereignty and supply chain resilience, it must adopt a whole-of-sector approach. 
Canada imports approximately 70 per cent of the medicines Canadians rely on, yet accounts for just two per cent of the global pharmaceutical market, leaving it exposed to decisions made beyond its borders, writes Angelique Berg.Photograph courtesy of Pixabay
Opinion
BY ANGELIQUE BERG
August 5, 2026

Amid growing pressures on global pharmaceutical supply chains, the

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MOST POPULAR

MORE Opinion

The future cost of Canada-EU’s LNG acceleration

opinionBY JOHANNE WHITMORE

War in Ethiopia

opinionBY GWYNNE DYER

Gander Social pitches sovereignty in social spaces with Canadian-made app

opinionBY BEN WALDMAN

How will Indigenous nations respond to Canada’s economic rupture?

opinionBY KATHERINE KOOSTACHIN

Fossil fuel expansion is ecocide: a crime against nature and humanity

opinionBY TREVOR HANCOCK